D. Alleva

发表

Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.

C. J. Burger, K. D. Elgert, D. Alleva, 1994, Journal of immunology.

Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice.

R. Pavlovich, C. Grant, D. Beller, 2000, Diabetes.

Macrophage priming and activation during fibrosarcoma growth: expression of c-myb, c-myc, c-fos, and c-fms.

D. Askew, C. J. Burger, K. D. Elgert, 1994, Immunological investigations.

Regulation of murine macrophage proinflammatory and anti‐inflammatory cytokines by ligands for peroxisome proliferator‐activated receptor‐γ: counter‐regulatory activity by IFN‐γ

P. Crowe, Eric B. Johnson, P. Conlon, 2002, Journal of Leukocyte Biology.

Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide.

D. Wegmann, P. Gottlieb, A. Putnam, 2002, Diabetes.

Enhanced early innate and T cell-mediated responses in subjects immunized with Anthrax Vaccine Adsorbed Plus CPG 7909 (AV7909).

E. Bernton, J. Lathey, R. Hopkins, 2014, Vaccine.

nhanced early innate and T cell-mediated responses in subjects mmunized with Anthrax Vaccine Adsorbed Plus CPG 7909 ( AV 7909 )

E. Bernton, J. Lathey, R. Hopkins, 2014 .

Immunomodulation in Type 1 Diabetes by NBI‐6024, an Altered Peptide Ligand of the Insulin B(9−23) Epitope

R. Maki, P. Gottlieb, A. Putnam, 2006, Scandinavian journal of immunology.

Interferon-γ reduces tumor-induced Ia− macrophage-mediated suppression: role of prostaglandin E2, Ia, and tumor necrosis factor-α

C. J. Burger, K. D. Elgert, D. Alleva, 1993 .

SJL and NOD macrophages are uniquely characterized by genetically programmed, elevated expression of the IL‐12(p40) gene, suggesting a conserved pathway for the induction of organ‐specific autoimmunity

Eric B. Johnson, P. Conlon, D. Beller, 2001, Journal of leukocyte biology.

Intrinsic defects in macrophage IL-12 production associated with immune dysfunction in the MRL/++ and New Zealand Black/White F1 lupus-prone mice and the Leishmania major-susceptible BALB/c strain.

D. Beller, D. Alleva, S. Kaser, 1998, Journal of immunology.

Susceptible BALB / c Strain Leishmania major Lupus-Prone Mice and the 1 Black / White F Dysfunction in the MRL / + + and New Zealand Production Associated with Immune Intrinsic Defects in Macrophage IL-12

D. Beller, D. Alleva, S. Kaser, 1998 .

Characterization of the Native Form of Anthrax Lethal Factor for Use in the Toxin Neutralization Assay

J. Catania, Jie Feng, J. Lathey, 2013, Clinical and Vaccine Immunology.

IL-15 functions as a potent autocrine regulator of macrophage proinflammatory cytokine production: evidence for differential receptor subunit utilization associated with stimulation or inhibition.

M. Fenton, M. A. Monroy, D. Beller, 1997, Journal of immunology.

Persistence of immune responses to altered and native myelin antigens in patients with multiple sclerosis treated with altered peptide ligand.

A. Bar-Or, J. Antel, P. Duquette, 2002, Clinical immunology.

Promotion of macrophage-stimulated autoreactive T cell proliferation by interleukin-10: counteraction of macrophage suppressor activity during tumor growth.

K. D. Elgert, D. Alleva, 1995, Immunobiology.

Tumour Growth Causes Suppression of Autoreactive T‐Cell Proliferation by Disrupting Macrophage Responsiveness to Interferon‐γ

C. J. Burger, K. D. Elgert, D. Alleva, 1994, Scandinavian journal of immunology.

Tumor-induced macrophage tumor necrosis factor-alpha production suppresses autoreactive T cell proliferation.

C. J. Burger, K. D. Elgert, D. Alleva, 1993, Immunobiology.

Experimental Autoimmune Encephalomyelitis Develops in CC Chemokine Receptor 7‐deficient Mice with Altered T‐cell Responses

R. Maki, S. Lechner, P. Hevezi, 2006, Scandinavian journal of immunology.

Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452

G. V. van Dam, H. Boersma, M. Brom, 2022, Vaccine.

Taxol, a microtubule-stabilizing antineoplastic agent, differentially regulates normal and tumor-bearing host macrophage nitric oxide production.

D. Mullins, C. J. Burger, K. D. Elgert, 1997, Immunopharmacology.

Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-gamma: counter-regulatory activity by IFN-gamma.

P. Crowe, Eric B. Johnson, P. Conlon, 2002, Journal of leukocyte biology.

Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.

C. J. Burger, K. D. Elgert, D. Alleva, 1994, Oncology research.

A high-throughput chemotaxis assay for pharmacological characterization of chemokine receptors: Utilization of U937 monocytic cells.

R. Struthers, F. Lio, Sarah C Hudson, 2005, Journal of pharmacological and toxicological methods.

Reversal of Hyperglycemia and Suppression of Type 1 Diabetes in the NOD Mouse with Apoptotic DNA Immunotherapy™ (ADi™), ADi-100

S. Shabahang, A. Thakor, J. Rosenberg, 2020, Biomedicines.

Pharmacological Characterization of CXC Chemokine Receptor 3 Ligands and a Small Molecule Antagonist

Albert Zlotnik, A. Zlotnik, P. Gottlieb, 2005, Journal of Pharmacology and Experimental Therapeutics.

Tumor‐induced immune dysfunction: the macrophage connection

D. Mullins, K. D. Elgert, D. Alleva, 1998, Journal of leukocyte biology.

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial

A. Evans, M. Filippi, C. Pozzilli, 2000, Nature Medicine.

Gene Array Analysis Comparison between Rat Collagen‐induced Arthritis and Human Rheumatoid Arthritis

P. Hevezi, H. Soto, A. Zlotnik, 2008, Scandinavian journal of immunology.

Aberrant cytokine expression and autocrine regulation characterize macrophages from young MRL+/+ and NZB/W F1 lupus-prone mice.

D. Beller, D. Alleva, S. Kaser, 1997, Journal of immunology.

A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin.

A. Gaur, W. Kwok, P. Gottlieb, 2001, The Journal of clinical investigation.

Development of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452

J. Yee, S. Ronca, S. Nagre, 2021, Vaccine.

Cutting Edge: Diabetes-Associated Quantitative Trait Locus, Idd4, Is Responsible for the IL-12p40 Overexpression Defect in Nonobese Diabetic (NOD) Mice

R. Maki, Eric B. Johnson, F. Lio, 2003, The Journal of Immunology.

Cuttine edge: diabetes-associated quantitative trait locus, Idd4, is responsible for the IL-12p40 overexpression defect in nonobese diabetic (NOD) mice.

R. Maki, Eric B. Johnson, F. Lio, 2003, Journal of immunology.

Amelioration of Glucose Intolerance by the Synthetic Androstene HE3286: Link to Inflammatory Pathways

J. Olefsky, C. Ahlem, Min Lu, 2010, Journal of Pharmacology and Experimental Therapeutics.

Identification of CC Chemokine Receptor 7 Residues Important for Receptor Activation*

S. Nickolls, R. Struthers, A. Pahuja, 2004, Journal of Biological Chemistry.

A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452

D. van Baarle, G. V. van Dam, S. Kruijff, 2023, Vaccine.

Amelioration of Glucose Intolerance by the Synthetic Androstene HE3286: Link to Inflammatory Pathways

J. Olefsky, C. Ahlem, Min Lu, 2010, Journal of Pharmacology and Experimental Therapeutics.

Zeitschrift Für Immunitätsforschung Editors Editor-in-chief Gustav Fischer Verlag @bullet Stuttgart @bullet New York @bullet 1993 Tumor-induced Macrophage Tumor Necrosis Factor-oc Production Suppresses Autoreactive T Cell Proliferation 430 Induction of Ige and Iggl in Human B Cell Cultures with Stap

R. Brezinschek, G. Vanham, S. Euvrard, 2011 .

An antigen-specific immunotherapeutic, AKS-107, deletes insulin-specific B cells and prevents murine autoimmune diabetes

C. Wasserfall, D. Alleva, Todd C. Zion, 2024, Frontiers in immunology.